Queensland Emory Development (QED) Alliance
The Queensland Emory Development Alliance (QED) is a biomedical research and development partnership between The University of Queensland, the QIMR Berghofer Medical Research Institute and Emory University to collaborate on new drugs and vaccines for preventing and treating cancer, neurological, and infectious diseases. More than
The Queensland Emory Development Alliance, initiated in 2012 and extending through 2022, builds on existing and new relationships between the three institutions to generate a pipeline of synergistic, exciting new commercial opportunities from small molecules to biologics.
The QED Alliance is an example of Emory’s increasing global presence in education and research. The alliance is devoted to identifying collaborative opportunities for advancing science and technology, from fundamental research to commercialization of therapies to confront global health challenges.
The research and development capabilities of the three institutions working together will be significantly enhanced through a collaborative approach to discovery and technology transfer.